Our Team
Our team of world-class scientists, builders and operators use their deep industry expertise to power the creation of life-transforming cell and gene therapies.
// About ElevateBio
Meet Our Team of Industry Experts
Board of Directors
We are advised and supported by a team of world-class technology and biotechnology industry experts with unmatched track records in building iconic companies and creating value in the field of rare disease and cell and gene therapy.
David Hallal
CEO of Scholar Rock and Executive Chairman, ElevateBio
Vikas Sinha
CFO of Scholar Rock
Ansbert Gadicke
Co-founder of MPM Capital
Morana Jovan-Embiricos, Ph.D.
Managing Partner of F2 Ventures
Germano Giuliani
Former CEO, Giuliani Pharma; Board of Directors, HBM Healthcare AH; Investment Committee Royalty Pharma
Khalil Barrage
Managing Director of The Invus Group
Karan Takhar
Managing Director, Matrix Capital Management Company
Navneet Govil
Managing Partner, SoftBank
Ger Brophy
Interim Chief Executive Officer of ElevateBio
Our Company’s Co‑Founders
We were founded in 2017 by three industry leaders who asked the question: what could revolutionize medicine in the next 50 years?
Investors
Committed to enabling innovative cell and gene therapy companies
